Shares in Pulmatrix (NSDQ:PULM) jumped more than 8% today on rumors that the company’s collaboration partner Mylan (NSDQ:MYL) may be interested in a takeover bid.
In 2015, the 2 companies inked an ex-U.S. development deal for PUR0200, Pulmatrix’s investigational bronchodilator for the treatment of chronic obstructive pulmonary disease. Mylan had an option on the rights to the COPD candidate, but reportedly did not exercise it.
Get the full story at our sister site, Drug Delivery Business News.
The post Pulmatrix jumps 8% on rumors of potential Mylan takeover bid appeared first on MassDevice.
from MassDevice http://ift.tt/2nvEKUf
Cap comentari:
Publica un comentari a l'entrada